Skip to main content

Table 2 Patient demographics and outcomes between matched DRG severity score 3-4

From: Impact of the SARS-CoV-2 (COVID19) pandemic on the morbidity and mortality of high risk patients undergoing surgery: a non-inferiority retrospective observational study

PERIOD

PRECOVID GROUP (n= 236)

COVID GROUP (n=135)

PRECOVID VS COVID

(p value)

Age (years)

66 (64-68)

66 (63.5-69)

0.914

Sex, male (%)

165 (69.9)

75 (55,6)

0.007

SURGERY BY SPECIALTY

0.418

Digestive and Gynaecological, n (%)

53 (22.5)

32 (23.7)

 

Orthopaedics and Trauma, n (%)

34 (14.4)

27 (20)

 

Plastic and Neck, n (%)

23 (9.7)

18 (13.3)

 

Cardiovascular and thoracic, n (%)

79 (33.5)

35 (26)

 

Neurosurgery, n (%)

29 (12.3)

15 (11.1)

 

Urology, n (%)

18 (7.6)

8 (5.9)

 

REINTERVENTION (%)

53 (22.5)

29 (21.5)

0-897

sICU

Per protocol, n (%)

152 (64.4)

60 (44.4)

0.000

Late admission, n (%)

12 (5.1)

6 (4.4)

 

Clavien Dindo

I, n (%)

67 (28.4)

33 (24.4)

 

II, n (%)

62 (26.3)

45 (33.3)

 

IIIa, n (%)

8 (3.4)

3 (2.2)

 

IIIb, n (%)

26 (11)

15 (11.1)

 

Iva, n (%)

21 (8.9)

11 (8.2)

 

IVb, n (%)

22 (9.3)

11 (8.2)

 

V, n (%)

30 (12.7)

17 (12.6)

 

III-V

107 (45.3)

56 (41.5)

0.515

Length of stay (days)

32.7

26.5

0.774

DESTINATION AT DISCHARGE

Home (%)

45.3

48

 

Dead (%)

12.7

12.6

1

Others (%)

42

39.4

 
  1. Only the patients with a DRG severity score 3-4 are shown. These are considered the patients with the highest risk of complications. DRG: Diagnosis Related Groups. Chi-square tests to compare the categorical variables, and the subtraction of variables using parametric or non-parametric tests for the continuous variables